Home > Blog > Eye Conditions > Diabetic Retinopathy > FDA Approves Lucentis for Diabetes-related Eye Disease

FDA Approves Lucentis for Diabetes-related Eye Disease

injectable eye drugsThe eye drug Lucentis has been approved by the Food and Drug Administration for treating the disease diabetic macular edema (DME). This drug was originally developed by Roche to treat cancer. Lucentis has also been approved to treat two eye disorders, macular degeneration and now, diabetic macular edema.

The leading cause of new cases of blindness in adults in the US is diabetes. Diabetic macular edema causes swelling and blurred vision. Without treatment, it can result in permanent vision loss. Of the 26,000 Americans with diabetes, more than 560,000 are estimated to have diabetic macular edema. All diabetics should have a comprehensive dilated annual eye examination to screen for this disease, as it may have no symptoms in the early stages.

Lucentis is an injection that is currently the only FDA-approved medication for diabetic macular edema. The typical treatment for DME in the US has been laser surgery; however, this surgery is limited in its ability to restore lost vision. The laser is able to slow down vision loss, as well as help stabilize vision.

Lucentis is also approved to treat wet macular degeneration. It helps control the production of weak blood vessels that leak in the retina.

Lucentis’ side-effects include increased pressure on the eyes, and possibly bleeding around the tissue that lines the eyelids.

As a cancer drug, Lucentis is injected in large quantities into the body. For treating the eye, the dosage is much smaller and is injected directly into the eye. Its sister drug, Avastin, is a very similar drug that is available in tiny doses. Avastin is made by the same drug company, and it is much cheaper per shot (approximately 3% of the cost of Lucentis, which runs more than $1600/month). However, using Avastin for diabetic macular edema has not been approved by the FDA, so Medicare cannot cover this “off-label” use now that Lucentis is approved.

Other eye diseases common to diabetics include diabetic retinopathy, cataracts and glaucoma. The effects of these eye diseases and diabetes can be reduced and/or managed through  a healthy diet, targeted supplementation and conscious lifestyle choices.


Natural Eye Care, Inc.
3 Paradies Lane
New Paltz, New York 12561
Phone: 845.475.4158

Natural Eye Care

NaturalEyeCare™ started in 1999 to help the public and professionals learn about complementary care in eye disease treatment.

The information and recommendations we offer are based on over 30 years of peer review research and personal clinical experience which guides us in providing a valuable resource to our readers, customers and patients regarding maintaining healthy vision naturally.

We believe that vision health is intimately connected to overall mental, physical and spiritual health. Therefore we encourage people to look at their overall lifestyle and diet as part of keeping healthy vision and reducing the risk of eye disease onset. This includes diet, regular exercise, and management of daily stress. If one has health issues such as high blood pressure, a thyroid imbalance, any autoimmune disease and/or are on medication(s), these possible contributions to eye disease should considered when working with your health care professional.

Please do not hesitate to call us at 845.475.4158 with any questions and concerns.

Recent Posts

Category